Bausch + Lomb Corporation

BLCO Healthcare Medical Instruments & Supplies

Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.

Revenue
+7.34%
EPS
+222.4%
Free cash flow
+182.5%
Total debt
+2.93%

Quarter to September 2026, against a year earlier

19.94 0.66 −3.20%
Market cap
$7.1B
P/E
0.0×
Fwd P/E
749×
Dividend yield
—
F-score
3/9
Altman Z
0.87
Beneish M
−2.52
Dividend safety
n/a

Bausch + Lomb Corporation (BLCO) Free cash flow

Alert me on Free cash flow

Bausch + Lomb Corporation's free cash flow for fiscal 2025 was −$66.0M, compared with −$59.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $252.0M. Over the past ten years it has ranged from −$198.0M (fiscal 2023) to $664.0M (fiscal 2021); the current reading is higher than 33% of that period. Bausch + Lomb Corporation ranks 14th of 51 Medical Instruments & Supplies companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 −$66.0M —
FY2024 −$59.0M —
FY2023 −$198.0M —
FY2022 $170.0M (74.40%)
FY2021 $664.0M 152.47%
FY2020 $263.0M —

Quarterly newest first

Period Free cash flow Change
Sep 2026 $178.0M 117.07%
Jun 2026 $82.0M —
Mar 2026 −$68.0M —
Dec 2025 $60.0M (4.76%)
20 more quarters

Against its own ten years

Low −$198.0M High $664.0M
Ten-year median $55.5M
Current reading's percentile 33

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on BLCO